This metabolic shift is particularly important for individuals with prediabetes or metabolic syndrome, where insulin resistance drives both weight gain and energy dysregulation
The first GMF was created in 1994, and since then, the use of GMFs has grown rapidly
Clinical Evidence for Weight Loss and Metabolic Health A Phase 2 trial published in NEJM (2023) reported approximately 24.2% mean body weight reduction over 48 weeks at the highest dose, alongside improvements in fasting glucose, insulin sensitivity, triglycerides, and waist circumference
Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men
The recommended frequency depends on your health goals and how your body responds
50 100 200 250 500 1000+ Other Products in 'Health Supplement' category